Exposure-based therapy

BEHAVIORAL3 trials

Sponsors

Laureate Institute for Brain Research, Inc., University of Texas at Austin

Conditions

AnxietyDepressionGeneralized Anxiety DisorderObsessive-Compulsive DisorderPanic DisorderPost Traumatic Stress DisorderSocial Anxiety Disorder

Unknown Phase

Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response

CompletedNCT02807480

Laureate Institute for Brain Research, Inc.Generalized Anxiety Disorder

Start: 2016-06-30End: 2022-03-04Updated: 2024-03-26

Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome (AAC-BeT)

RecruitingNCT04426461

Laureate Institute for Brain Research, Inc.Anxiety, Depression

Start: 2020-09-11End: 2025-06-30Target: 220Updated: 2025-06-13

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

RecruitingNCT05467683

University of Texas at AustinGeneralized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic Disorder +2

Start: 2022-11-02End: 2027-02-28Target: 600Updated: 2026-02-19

Related Papers

Prediction of generalized anxiety disorder treatment outcomes with neurobehavioral responses to approach-avoidance conflict: a randomized clinical trial.

2025-07-051 citations

Neural activity to reward and loss predicting treatment outcomes for adults with generalized anxiety disorder: A randomized clinical trial

Journal of Mood and Anxiety Disorders2025-01-081 citations

A randomized clinical trial of behavioral activation and exposure-based therapy for adults with generalized anxiety disorder.

2023-06-096 citations

CO2 reactivity as a biomarker of exposure-based therapy non-response: study protocol

BMC Psychiatry2022-12-278 citations

Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder

Trials2020-01-0626 citations